| |
|
|---|
| 成交價 | 昨收 | 漲跌價 | 漲跌幅 | 振幅 | 開盤 | 最高 | 最低 | | 67.2 | 67.5 | -0.3 | -0.44% | 3.41% | 65.2 | 67.5 | 65.2 | | 成交張數 | 成交金額 | 成交筆數 | 成交均張 | 成交均價 | PBR | PER | PEG | | 80 | 532.4萬 | 66 | 1.2張/筆 | 66.95元 | 12.7 | N/A | N/A | | 昨日張數 | 昨日金額 | 昨日筆數 | 昨日均張 | 昨日均價 | 昨漲跌價 (幅) | | 30 | 203.3萬 | 21 | 1.4張/筆 | 67.12元 | -0.2 (-0.3%) | 連漲連跌: 連3跌 ( -0.8元 / -1.18%)
財報評分: 最新45分 / 平均43分 上櫃指數: 245.36 (2.71 / +1.12%) | | | |
* 自2013年1月實施IFRSs後, 各項產品之單月營收已改為各公司自願申報, 若有無資料之情形, 即為該公司無申報產品營收, 請使用人多加留意。 | | |
| 月別 | 當月股價 | 項目 | 產品/業務 | 單月營收 | 累計營收 | | 開盤 | 收盤 | 最高 | 最低 | 漲跌
(元) | 漲跌
(%) | 營收
(億) | 佔比
(%) | 月增
(%) | 年增
(%) | 營收
(億) | 佔比
(%) | 年增
(%) | | 2024/03 | 52.5 | 69.5 | 71.4 | 52.2 | +14.9 | +27.29 | (1) | 原料藥/學名藥/新藥 | 0.486 | 100 | +240.5 | +256.4 | 0.734 | 100 | +98.6 | | 減 | 銷貨退回及折讓 | 0 | 0 | - | - | 0 | 0 | - | | 合計 | 業務營收淨額 | 0.486 | 100 | +240.5 | +256.4 | 0.734 | 100 | +98.6 | | 2024/02 | 47.4 | 54.6 | 55.5 | 42.1 | +9 | +19.74 | (1) | 原料藥/學名藥/新藥 | 0.143 | 100 | +35.1 | +36.1 | 0.248 | 100 | +6.41 | | 減 | 銷貨退回及折讓 | 0 | 0 | - | - | 0 | 0 | - | | 合計 | 業務營收淨額 | 0.143 | 100 | +35.1 | +36.1 | 0.248 | 100 | +6.41 | | 2024/01 | 41.3 | 45.6 | 45.65 | 38.8 | +4.3 | +10.41 | (1) | 原料藥/學名藥/新藥 | 0.106 | 100 | -84.4 | -17.8 | 0.106 | 100 | -17.8 | | 減 | 銷貨退回及折讓 | 0 | 0 | - | - | 0 | 0 | - | | 合計 | 業務營收淨額 | 0.106 | 100 | -84.4 | -17.8 | 0.106 | 100 | -17.8 | | 2023/12 | 41.1 | 41.3 | 42.3 | 38 | +0.2 | +0.49 | (1) | 原料藥/學名藥/新藥 | 0.677 | 100 | +892.9 | +286.4 | 2.72 | 100 | +51.9 | | 減 | 銷貨退回及折讓 | 0 | 0 | - | - | 0 | 0 | - | | 合計 | 業務營收淨額 | 0.677 | 100 | +892.9 | +286.4 | 2.72 | 100 | +51.8 | | 2023/11 | 29.8 | 41.1 | 44.5 | 27.85 | +11 | +36.54 | (1) | 原料藥/學名藥/新藥 | 0.0681 | 100 | -69.8 | -76.5 | 2.04 | 100 | +26.4 | | 減 | 銷貨退回及折讓 | 0 | 0 | - | - | 0 | 0 | - | | 合計 | 業務營收淨額 | 0.0681 | 100 | -69.8 | -76.5 | 2.04 | 100 | +26.4 | | 月別 | 當月股價 | 項目 | 產品/業務 | 單月營收 | 累計營收 | | 開盤 | 收盤 | 最高 | 最低 | 漲跌
(元) | 漲跌
(%) | 營收
(億) | 佔比
(%) | 月增
(%) | 年增
(%) | 營收
(億) | 佔比
(%) | 年增
(%) | | 2023/10 | 21.8 | 30.1 | 34.1 | 21.7 | +8.7 | +40.65 | (1) | 原料藥/學名藥/新藥 | 0.226 | 100 | -50 | +11.2 | 1.97 | 100 | +49.1 | | 減 | 銷貨退回及折讓 | 0 | 0 | - | - | 0 | 0 | - | | 合計 | 業務營收淨額 | 0.226 | 100 | -50 | +11.2 | 1.97 | 100 | +49 | | 2023/09 | 21.8 | 21.4 | 22.15 | 19.9 | -0.35 | -1.61 | (1) | 原料藥/學名藥/新藥 | 0.451 | 100 | +252.2 | +150.4 | 1.75 | 100 | +55.9 | | 減 | 銷貨退回及折讓 | 0 | 0 | - | - | 0 | 0 | - | | 合計 | 業務營收淨額 | 0.451 | 100 | +252.2 | +150.4 | 1.75 | 100 | +55.8 | | 2023/08 | 22.8 | 21.75 | 23.2 | 21.35 | -1.15 | -5.02 | (1) | 原料藥/學名藥/新藥 | 0.128 | 100 | +25.2 | +136.4 | 1.29 | 100 | +37.8 | | 減 | 銷貨退回及折讓 | 0 | 0 | - | - | 0 | 0 | - | | 合計 | 業務營收淨額 | 0.128 | 100 | +25.2 | +136.4 | 1.29 | 100 | +37.7 | | 2023/07 | 22.2 | 22.9 | 23.6 | 21.65 | +0.7 | +3.15 | (1) | 原料藥/學名藥/新藥 | 0.102 | 100 | -71.4 | -45.1 | 1.17 | 100 | +31.8 | | 減 | 銷貨退回及折讓 | 0 | 0 | - | - | 0 | 0 | - | | 合計 | 業務營收淨額 | 0.102 | 100 | -71.4 | -45.1 | 1.17 | 100 | +31.7 | | 2023/06 | 20.45 | 22.2 | 25.4 | 20.4 | +1.5 | +7.25 | (1) | 原料藥/學名藥/新藥 | 0.358 | 100 | +164.3 | +75.6 | 1.06 | 100 | +52.3 | | 減 | 銷貨退回及折讓 | 0 | 0 | - | - | 0 | 0 | - | | 合計 | 業務營收淨額 | 0.358 | 100 | +164.3 | +75.6 | 1.06 | 100 | +52.1 | | 月別 | 當月股價 | 項目 | 產品/業務 | 單月營收 | 累計營收 | | 開盤 | 收盤 | 最高 | 最低 | 漲跌
(元) | 漲跌
(%) | 營收
(億) | 佔比
(%) | 月增
(%) | 年增
(%) | 營收
(億) | 佔比
(%) | 年增
(%) | | 2023/05 | 19.65 | 20.7 | 22.1 | 19.45 | +1.05 | +5.34 | (1) | 原料藥/學名藥/新藥 | 0.135 | 100 | -32.9 | +46.2 | 0.707 | 100 | +42.6 | | 減 | 銷貨退回及折讓 | 0 | 0 | - | - | 0 | 0 | - | | 合計 | 業務營收淨額 | 0.135 | 100 | -32.9 | +44.9 | 0.707 | 100 | +42.4 | | 2023/04 | 19.85 | 19.65 | 21.3 | 19.1 | -0.3 | -1.5 | (1) | 原料藥/學名藥/新藥 | 0.202 | 100 | +48 | +286.4 | 0.571 | 100 | +41.8 | | 減 | 銷貨退回及折讓 | 0 | 0 | - | - | 0 | 0 | - | | 合計 | 業務營收淨額 | 0.202 | 100 | +48 | +286.4 | 0.571 | 100 | +41.8 | | 2023/03 | 16.35 | 19.95 | 22.45 | 15.8 | +3.55 | +21.65 | (1) | 原料藥/學名藥/新藥 | 0.136 | 100 | +30.1 | -18.4 | 0.37 | 100 | +5.41 | | 減 | 銷貨退回及折讓 | 0 | 0 | - | - | 0 | 0 | - | | 合計 | 業務營收淨額 | 0.136 | 100 | +30.1 | -18.4 | 0.37 | 100 | +5.41 | | 2023/02 | 15.7 | 16.4 | 16.95 | 14.65 | +0.65 | +4.13 | (1) | 原料藥/學名藥/新藥 | 0.105 | 100 | -18.5 | +37.1 | 0.233 | 100 | +27.1 | | 減 | 銷貨退回及折讓 | 0 | 0 | - | - | 0 | 0 | - | | 合計 | 業務營收淨額 | 0.105 | 100 | -18.5 | +37.1 | 0.233 | 100 | +27.1 | | 2023/01 | 16 | 15.75 | 16.4 | 15.55 | -0.3 | -1.87 | (1) | 原料藥/學名藥/新藥 | 0.129 | 100 | -26.6 | +19.9 | 0.129 | 100 | +19.9 | | 減 | 銷貨退回及折讓 | 0 | 0 | - | - | 0 | 0 | - | | 合計 | 業務營收淨額 | 0.129 | 100 | -26.6 | +19.9 | 0.129 | 100 | +19.9 | | 月別 | 當月股價 | 項目 | 產品/業務 | 單月營收 | 累計營收 | | 開盤 | 收盤 | 最高 | 最低 | 漲跌
(元) | 漲跌
(%) | 營收
(億) | 佔比
(%) | 月增
(%) | 年增
(%) | 營收
(億) | 佔比
(%) | 年增
(%) | | 2022/12 | 14.55 | 16.05 | 17.45 | 14.3 | +1.5 | +10.31 | (1) | 原料藥/學名藥/新藥 | 0.175 | 100 | -39.7 | +167 | 1.79 | 100 | -6.85 | | 減 | 銷貨退回及折讓 | 0 | 0 | - | - | 0 | 0 | - | | 合計 | 業務營收淨額 | 0.175 | 100 | -39.7 | +139.6 | 1.79 | 100 | -9.32 | | 2022/11 | 14.6 | 14.55 | 15.15 | 13.95 | -0.05 | -0.34 | (1) | 原料藥/學名藥/新藥 | 0.29 | 100 | +43 | +41.8 | 1.61 | 100 | -13 | | 減 | 銷貨退回及折讓 | 0 | 0 | - | - | 0 | 0 | - | | 合計 | 業務營收淨額 | 0.29 | 100 | +43 | +41.8 | 1.61 | 100 | -15 | | 2022/10 | 15 | 14.6 | 16.2 | 13.55 | +4.1 | +39.05 | (1) | 原料藥/學名藥/新藥 | 0.203 | 100 | +12.7 | +118 | 1.32 | 99.9 | -19.8 | | 減 | 銷貨退回及折讓 | 0 | 0 | - | - | 0 | 0 | - | | 合計 | 業務營收淨額 | 0.203 | 100 | +12.7 | +118 | 1.32 | 100 | -21.9 | | 2022/09 | 10.1 | 10.5 | 12 | 9.79 | +0.4 | +3.96 | (1) | 原料藥/學名藥/新藥 | 0.18 | 100 | +232.4 | +136.3 | 1.12 | 99.9 | -28 | | 減 | 銷貨退回及折讓 | 0 | 0 | - | - | 0 | 0 | - | | 合計 | 業務營收淨額 | 0.18 | 100 | +232.4 | +112.7 | 1.12 | 100 | -30 | | 2022/08 | 13 | 10.1 | 13.25 | 9.32 | -3 | -22.9 | (1) | 原料藥/學名藥/新藥 | 0.0542 | 100 | -70.9 | -67.1 | 0.94 | 99.9 | -36.5 | | 減 | 銷貨退回及折讓 | 0 | 0 | - | - | 0 | 0 | - | | 合計 | 業務營收淨額 | 0.0542 | 100 | -70.9 | -68.4 | 0.94 | 100 | -38 | | 月別 | 當月股價 | 項目 | 產品/業務 | 單月營收 | 累計營收 | | 開盤 | 收盤 | 最高 | 最低 | 漲跌
(元) | 漲跌
(%) | 營收
(億) | 佔比
(%) | 月增
(%) | 年增
(%) | 營收
(億) | 佔比
(%) | 年增
(%) | | 2022/07 | 12.35 | 13.1 | 15.1 | 12.15 | +0.65 | +5.22 | (1) | 原料藥/學名藥/新藥 | 0.186 | 100 | -8.52 | +25.3 | 0.885 | 99.9 | -32.7 | | 減 | 銷貨退回及折讓 | 0 | 0 | - | - | 0 | 0 | - | | 合計 | 業務營收淨額 | 0.186 | 100 | -8.52 | +13.6 | 0.886 | 100 | -34.1 | | 2022/06 | 13.5 | 12.45 | 13.55 | 12.15 | -1.25 | -9.12 | (1) | 原料藥/學名藥/新藥 | 0.204 | 100 | +120 | +196.9 | 0.699 | 99.9 | -40.1 | | 減 | 銷貨退回及折讓 | 0 | 0 | - | - | 0 | 0 | - | | 合計 | 業務營收淨額 | 0.204 | 100 | +118.1 | +167.6 | 0.7 | 100 | -40.8 | | 2022/05 | 14.65 | 13.7 | 15.8 | 13.5 | -0.95 | -6.48 | (1) | 原料藥/學名藥/新藥 | 0.0926 | 99.2 | +77.3 | -64.8 | 0.495 | 99.8 | -54.9 | | (2) | 體溫量測產品 | 0.0008 | 0.85 | - | +7800 | - | - | - | | 減 | 銷貨退回及折讓 | 0 | 0 | - | - | 0 | 0 | - | | 合計 | 業務營收淨額 | 0.0934 | 100 | +78.8 | -64.5 | 0.496 | 100 | -55.1 | | 2022/04 | 13.85 | 14.65 | 16.95 | 13.6 | +0.55 | +3.9 | (1) | 原料藥/學名藥/新藥 | 0.0522 | 100 | -68.7 | -58.5 | 0.403 | 100 | -51.7 | | 減 | 銷貨退回及折讓 | 0 | 0 | - | - | 0 | 0 | - | | 合計 | 業務營收淨額 | 0.0522 | 100 | -68.7 | -58.5 | 0.403 | 100 | -52.2 | | 2022/03 | 14.55 | 14.1 | 15.1 | 13.3 | -0.45 | -3.09 | (1) | 原料藥/學名藥/新藥 | 0.167 | 100 | +118.4 | -60.5 | 0.351 | 100 | -50.5 | | 減 | 銷貨退回及折讓 | 0 | 0 | - | - | 0 | 0 | - | | 合計 | 業務營收淨額 | 0.167 | 100 | +118.4 | -61.2 | 0.351 | 100 | -51 | | 月別 | 當月股價 | 項目 | 產品/業務 | 單月營收 | 累計營收 | | 開盤 | 收盤 | 最高 | 最低 | 漲跌
(元) | 漲跌
(%) | 營收
(億) | 佔比
(%) | 月增
(%) | 年增
(%) | 營收
(億) | 佔比
(%) | 年增
(%) | | 2022/02 | 15.6 | 14.55 | 15.9 | 14.55 | -1.05 | -6.73 | (1) | 原料藥/學名藥/新藥 | 0.0765 | 100 | -28.7 | -44.4 | 0.184 | 100 | -35.8 | | 減 | 銷貨退回及折讓 | 0 | 0 | - | - | 0 | 0 | - | | 合計 | 業務營收淨額 | 0.0765 | 100 | -28.7 | -44.4 | 0.184 | 100 | -35.8 | | 2022/01 | 15.9 | 15.6 | 16.45 | 15.1 | -0.3 | -1.89 | (1) | 原料藥/學名藥/新藥 | 0.107 | 100 | +63.4 | -27.8 | 0.107 | 100 | -27.8 | | 減 | 銷貨退回及折讓 | 0 | 0 | - | - | 0 | 0 | - | | 合計 | 業務營收淨額 | 0.107 | 100 | +46.7 | -27.8 | 0.107 | 100 | -27.8 | | 2021/12 | 16.2 | 15.9 | 17.3 | 15.55 | -0.2 | -1.24 | (1) | 原料藥/學名藥/新藥 | 0.0656 | 89.7 | -68 | -80.6 | 1.92 | 97.3 | -27.4 | | (2) | 體溫量測產品 | 0.0075 | 10.3 | - | 0 | - | - | - | | 減 | 銷貨退回及折讓 | 0 | 0 | - | - | 0 | 0 | - | | 合計 | 業務營收淨額 | 0.0731 | 100 | -64.3 | -78.8 | 1.97 | 100 | -26.3 | | 2021/11 | 15.15 | 16.1 | 17.5 | 14.95 | +1.05 | +6.98 | (1) | 原料藥/學名藥/新藥 | 0.205 | 100 | +119.9 | -3.94 | 1.85 | 97.6 | -19.6 | | 減 | 銷貨退回及折讓 | 0 | 0 | - | - | 0 | 0 | - | | 合計 | 業務營收淨額 | 0.205 | 100 | +119.9 | -3.94 | 1.9 | 100 | -18.5 | | 2021/10 | 15.9 | 15.05 | 15.95 | 15 | -0.85 | -5.35 | (1) | 原料藥/學名藥/新藥 | 0.0931 | 100 | +22.2 | -70 | 1.65 | 97.3 | -21.2 | | 減 | 銷貨退回及折讓 | 0 | 0 | - | - | 0 | 0 | - | | 合計 | 業務營收淨額 | 0.0931 | 100 | +9.98 | -70 | 1.69 | 100 | -20 | | 月別 | 當月股價 | 項目 | 產品/業務 | 單月營收 | 累計營收 | | 開盤 | 收盤 | 最高 | 最低 | 漲跌
(元) | 漲跌
(%) | 營收
(億) | 佔比
(%) | 月增
(%) | 年增
(%) | 營收
(億) | 佔比
(%) | 年增
(%) | | 2021/09 | 15.7 | 15.9 | 16.15 | 15.3 | +0.25 | +1.6 | (1) | 原料藥/學名藥/新藥 | 0.0762 | 90 | -53.7 | +497.3 | 1.56 | 97.2 | -12.7 | | (2) | 體溫量測產品 | 0.0084 | 9.98 | +24.1 | +12.7 | - | - | - | | 減 | 銷貨退回及折讓 | 0 | 0 | - | - | 0 | 0 | - | | 合計 | 業務營收淨額 | 0.0847 | 100 | -50.6 | +317.9 | 1.6 | 100 | -11.4 | | 2021/08 | 15.65 | 15.65 | 16.25 | 15.45 | 0 | 0 | (1) | 原料藥/學名藥/新藥 | 0.165 | 96 | +10.8 | -23.3 | 1.48 | 97.6 | -16.4 | | (2) | 體溫量測產品 | 0.0068 | 3.97 | -55.6 | - | - | - | - | | 減 | 銷貨退回及折讓 | 0 | 0 | - | - | 0 | 0 | - | | 合計 | 業務營收淨額 | 0.171 | 100 | +4.57 | -20.1 | 1.52 | 100 | -15.1 | | 2021/07 | 15.6 | 15.65 | 16.6 | 15.3 | +0.05 | +0.32 | (1) | 原料藥/學名藥/新藥 | 0.149 | 90.6 | +116.7 | +29.4 | 1.32 | 97.7 | -15.4 | | (2) | 體溫量測產品 | 0.0153 | 9.35 | +104.5 | +936.5 | - | - | - | | 減 | 銷貨退回及折讓 | 0 | 0 | - | - | 0 | 0 | - | | 合計 | 業務營收淨額 | 0.164 | 100 | +115.5 | +40.9 | 1.35 | 100 | -14.4 | | 2021/06 | 17.2 | 15.6 | 17.2 | 15.2 | -1.4 | -8.24 | (1) | 原料藥/學名藥/新藥 | 0.0686 | 90.1 | -73.9 | +65.7 | 1.17 | 98.7 | -19 | | (2) | 體溫量測產品 | 0.0075 | 9.86 | +74900 | 0 | - | - | - | | 減 | 銷貨退回及折讓 | 0 | 0 | - | - | 0 | 0 | - | | 合計 | 業務營收淨額 | 0.0761 | 100 | -71.1 | +55.6 | 1.18 | 100 | -18.9 | | 月別 | 當月股價 | 項目 | 產品/業務 | 單月營收 | 累計營收 | | 開盤 | 收盤 | 最高 | 最低 | 漲跌
(元) | 漲跌
(%) | 營收
(億) | 佔比
(%) | 月增
(%) | 年增
(%) | 營收
(億) | 佔比
(%) | 年增
(%) | | 2021/05 | 18 | 17 | 20 | 15.9 | -0.6 | -3.41 | (1) | 原料藥/學名藥/新藥 | 0.263 | 100 | +109.1 | -30.1 | 1.1 | 99.3 | -21.5 | | (2) | 體溫量測產品 | 0 | 0 | - | -98.7 | - | - | - | | 減 | 銷貨退回及折讓 | 0 | 0 | - | - | 0 | 0 | - | | 合計 | 業務營收淨額 | 0.263 | 100 | +109.1 | -30.2 | 1.11 | 100 | -21.4 | | 2021/04 | 17 | 17.6 | 20.35 | 16.3 | +0.85 | +5.07 | (1) | 原料藥/學名藥/新藥 | 0.126 | 100 | -70.2 | -50 | 0.835 | 99.1 | -18.4 | | 減 | 銷貨退回及折讓 | 0 | 0 | - | - | 0 | 0 | - | | 合計 | 業務營收淨額 | 0.126 | 100 | -70.8 | -50 | 0.842 | 100 | -18.2 | | 2021/03 | 19 | 16.75 | 19.15 | 16 | -1.4 | -7.71 | (1) | 原料藥/學名藥/新藥 | 0.423 | 98.3 | +207.6 | +113.9 | 0.709 | 99 | -8.04 | | (2) | 體溫量測產品 | 0.0075 | 1.74 | - | 0 | - | - | - | | 減 | 銷貨退回及折讓 | 0 | 0 | - | - | 0 | 0 | - | | 合計 | 業務營收淨額 | 0.43 | 100 | +213.1 | +109.8 | 0.716 | 100 | -7.96 | | 2021/02 | 15 | 18.15 | 18.8 | 14.9 | +3.15 | +21 | (1) | 原料藥/學名藥/新藥 | 0.137 | 100 | -7.43 | -32.4 | 0.286 | 100 | -50.1 | | 減 | 銷貨退回及折讓 | 0 | 0 | - | - | 0 | 0 | - | | 合計 | 業務營收淨額 | 0.137 | 100 | -7.43 | -32.4 | 0.286 | 100 | -50.1 | | 2021/01 | 17.25 | 15 | 17.25 | 14.8 | -2.35 | -13.54 | (1) | 原料藥/學名藥/新藥 | 0.149 | 100 | -56.1 | -59.8 | 0.149 | 100 | -59.8 | | 減 | 銷貨退回及折讓 | 0 | 0 | - | - | 0 | 0 | - | | 合計 | 業務營收淨額 | 0.149 | 100 | -57 | -59.8 | 0.149 | 100 | -59.8 | | 月別 | 當月股價 | 項目 | 產品/業務 | 單月營收 | 累計營收 | | 開盤 | 收盤 | 最高 | 最低 | 漲跌
(元) | 漲跌
(%) | 營收
(億) | 佔比
(%) | 月增
(%) | 年增
(%) | 營收
(億) | 佔比
(%) | 年增
(%) | | 2020/12 | 18.9 | 17.35 | 18.9 | 16.8 | -1.5 | -7.96 | (1) | 原料藥/學名藥/新藥 | 0.338 | 97.8 | +58.6 | -2.49 | 2.64 | 98.8 | -25.8 | | (2) | 體溫量測產品 | 0.0075 | 2.17 | - | 0 | - | - | - | | 減 | 銷貨退回及折讓 | 0 | 0 | - | - | 0 | 0 | - | | 合計 | 業務營收淨額 | 0.346 | 100 | +62.1 | -2.43 | 2.68 | 100 | -25.6 | | 2020/11 | 19.3 | 18.85 | 21.5 | 18.2 | -0.45 | -2.33 | (1) | 原料藥/學名藥/新藥 | 0.213 | 100 | -31.3 | -37.8 | 2.31 | 98.9 | -28.3 | | 減 | 銷貨退回及折讓 | 0 | 0 | - | - | 0 | 0 | - | | 合計 | 業務營收淨額 | 0.213 | 100 | -31.3 | -37.8 | 2.33 | 100 | -28.2 | | 2020/10 | 17 | 19.3 | 23.9 | 14.7 | +2.8 | +16.97 | (1) | 原料藥/學名藥/新藥 | 0.31 | 100 | +2332.1 | +65.5 | 2.09 | 98.8 | -27.2 | | 減 | 銷貨退回及折讓 | 0 | 0 | - | - | 0 | 0 | - | | 合計 | 業務營收淨額 | 0.31 | 100 | +1431.8 | +65.5 | 2.12 | 100 | -27 | | 2020/09 | 20.7 | 16.5 | 20.75 | 16.25 | -4.25 | -20.48 | (1) | 原料藥/學名藥/新藥 | 0.0128 | 63 | -94.1 | -95.7 | 1.78 | 98.6 | -33.7 | | (2) | 體溫量測產品 | 0.0075 | 37 | - | -5.18 | - | - | - | | 減 | 銷貨退回及折讓 | 0 | 0 | - | - | 0 | 0 | - | | 合計 | 業務營收淨額 | 0.0203 | 100 | -90.6 | -93.4 | 1.81 | 100 | -33.4 | | 2020/08 | 25 | 20.75 | 26.4 | 19.65 | -3.9 | -15.82 | (1) | 原料藥/學名藥/新藥 | 0.215 | 100 | +86.8 | -43.5 | 1.77 | 99 | -25.8 | | 減 | 銷貨退回及折讓 | 0 | 0 | - | - | 0 | 0 | - | | 合計 | 業務營收淨額 | 0.215 | 100 | +84.4 | -43.5 | 1.79 | 100 | -25.8 | | 月別 | 當月股價 | 項目 | 產品/業務 | 單月營收 | 累計營收 | | 開盤 | 收盤 | 最高 | 最低 | 漲跌
(元) | 漲跌
(%) | 營收
(億) | 佔比
(%) | 月增
(%) | 年增
(%) | 營收
(億) | 佔比
(%) | 年增
(%) | | 2020/07 | 23.5 | 24.65 | 34.2 | 20.95 | +1.2 | +5.12 | (1) | 原料藥/學名藥/新藥 | 0.115 | 98.7 | +177.5 | +0.2 | 1.56 | 98.9 | -22.5 | | (2) | 體溫量測產品 | 0.0015 | 1.27 | -80.3 | - | - | - | - | | 減 | 銷貨退回及折讓 | 0 | 0 | - | - | 0 | 0 | - | | 合計 | 業務營收淨額 | 0.116 | 100 | +138 | +1.49 | 1.57 | 100 | -22.4 | | 2020/06 | 18.7 | 23.45 | 26.65 | 16.5 | +4.95 | +26.76 | (1) | 原料藥/學名藥/新藥 | 0.0414 | 84.7 | -89 | -93 | 1.44 | 98.9 | -23.9 | | (2) | 體溫量測產品 | 0.0075 | 15.3 | +900 | 0 | - | - | - | | 減 | 銷貨退回及折讓 | 0 | 0 | - | - | 0 | 0 | - | | 合計 | 業務營收淨額 | 0.0489 | 100 | -87 | -91.8 | 1.46 | 100 | -23.9 | | 2020/05 | 11.7 | 18.5 | 23.75 | 11.15 | +7.2 | +63.72 | (1) | 原料藥/學名藥/新藥 | 0.376 | 99.8 | +49.4 | +55.9 | 1.4 | 99.4 | +7.51 | | (2) | 體溫量測產品 | 0.0008 | 0.2 | - | - | - | - | - | | 減 | 銷貨退回及折讓 | 0 | 0 | - | - | 0 | 0 | - | | 合計 | 業務營收淨額 | 0.377 | 100 | +49.7 | +56.2 | 1.41 | 100 | +7.07 | | 2020/04 | 8.44 | 11.3 | 11.95 | 8.44 | +2.61 | +30.03 | (1) | 原料藥/學名藥/新藥 | 0.252 | 100 | +27.4 | +6.88 | 1.02 | 99.3 | -3.5 | | 減 | 銷貨退回及折讓 | 0 | 0 | - | - | 0 | 0 | - | | 合計 | 業務營收淨額 | 0.252 | 100 | +22.8 | +6.88 | 1.03 | 100 | -3.98 | | 月別 | 當月股價 | 項目 | 產品/業務 | 單月營收 | 累計營收 | | 開盤 | 收盤 | 最高 | 最低 | 漲跌
(元) | 漲跌
(%) | 營收
(億) | 佔比
(%) | 月增
(%) | 年增
(%) | 營收
(億) | 佔比
(%) | 年增
(%) | | 2020/03 | 14.15 | 8.69 | 15.95 | 7.63 | -4.61 | -34.66 | (1) | 原料藥/學名藥/新藥 | 0.198 | 96.3 | -2.74 | -25.8 | 0.771 | 99 | -6.47 | | (2) | 體溫量測產品 | 0.0075 | 3.66 | - | 0 | - | - | - | | 減 | 銷貨退回及折讓 | 0 | 0 | - | - | 0 | 0 | - | | 合計 | 業務營收淨額 | 0.205 | 100 | +0.95 | -25.1 | 0.778 | 100 | -7.03 | | 2020/02 | 11.1 | 13.3 | 14.25 | 9.97 | +2.25 | +20.36 | (1) | 原料藥/學名藥/新藥 | 0.203 | 100 | -45.1 | -29.5 | 0.573 | 100 | +2.74 | | 減 | 銷貨退回及折讓 | 0 | 0 | - | - | 0 | 0 | - | | 合計 | 業務營收淨額 | 0.203 | 100 | -45.1 | -29.6 | 0.573 | 100 | +1.73 | | 2020/01 | 9.5 | 11.05 | 12 | 9.5 | +1.17 | +11.84 | (1) | 原料藥/學名藥/新藥 | 0.37 | 100 | +6.71 | +37.2 | 0.37 | 100 | +37.2 | | 減 | 銷貨退回及折讓 | 0 | 0 | - | - | 0 | 0 | - | | 合計 | 業務營收淨額 | 0.37 | 100 | +4.45 | +34.6 | 0.37 | 100 | +34.6 | | 2019/12 | 9.7 | 9.88 | 10.35 | 9.51 | +0.21 | +2.17 | (1) | 原料藥/學名藥/新藥 | 0.347 | 97.9 | +1.21 | -50.7 | 3.56 | 99 | - | | (2) | 體溫量測產品 | 0.0075 | 2.12 | - | -50.4 | - | - | - | | 減 | 銷貨退回及折讓 | 0 | 0 | - | - | 0 | 0 | - | | 合計 | 業務營收淨額 | 0.354 | 100 | +3.4 | -50.7 | 3.6 | 100 | -14.1 | | 2019/11 | 10.05 | 9.67 | 10.55 | 9.42 | -0.38 | -3.78 | (1) | 原料藥/學名藥/新藥 | 0.343 | 100 | +82.6 | +94.4 | 3.22 | 99.1 | - | | 減 | 銷貨退回及折讓 | 0 | 0 | - | - | 0 | 0 | - | | 合計 | 業務營收淨額 | 0.343 | 100 | +82.6 | +94.4 | 3.25 | 100 | -6.56 | | 月別 | 當月股價 | 項目 | 產品/業務 | 單月營收 | 累計營收 | | 開盤 | 收盤 | 最高 | 最低 | 漲跌
(元) | 漲跌
(%) | 營收
(億) | 佔比
(%) | 月增
(%) | 年增
(%) | 營收
(億) | 佔比
(%) | 年增
(%) | | 2019/10 | 10.8 | 10.05 | 11.4 | 9.9 | -0.75 | -6.94 | (1) | 原料藥/學名藥/新藥 | 0.188 | 100 | -37.5 | -68.3 | 2.87 | 99 | - | | 減 | 銷貨退回及折讓 | 0 | 0 | - | - | 0 | 0 | - | | 合計 | 業務營收淨額 | 0.188 | 100 | -39.1 | -68.3 | 2.9 | 100 | -12 | | 2019/09 | 9.93 | 10.8 | 11.9 | 9.85 | +0.91 | +9.2 | (1) | 原料藥/學名藥/新藥 | 0.3 | 97.4 | -21 | -0.34 | 2.69 | 99 | - | | (2) | 體溫量測產品 | 0.0079 | 2.57 | - | +188.7 | - | - | - | | 減 | 銷貨退回及折讓 | 0 | 0 | - | - | 0 | 0 | - | | 合計 | 業務營收淨額 | 0.308 | 100 | -19 | +1.37 | 2.72 | 100 | +0.36 | | 2019/08 | 10.65 | 9.89 | 11.1 | 9.75 | -0.76 | -7.14 | (1) | 原料藥/學名藥/新藥 | 0.38 | 100 | +231.6 | +84.7 | 2.39 | 99.1 | - | | 減 | 銷貨退回及折讓 | 0 | 0 | - | - | 0 | 0 | - | | 合計 | 業務營收淨額 | 0.38 | 100 | +231.6 | +64.7 | 2.41 | 100 | +0.23 | | 2019/07 | 9.82 | 10.65 | 12.2 | 9.81 | +0.85 | +8.67 | (1) | 原料藥/學名藥/新藥 | 0.115 | 100 | -80.6 | - | 2.01 | 99 | - | | 減 | 銷貨退回及折讓 | 0 | 0 | - | - | 0 | 0 | - | | 合計 | 業務營收淨額 | 0.115 | 100 | -80.8 | -72.1 | 2.03 | 100 | -6.62 | | 2019/06 | 9.9 | 9.8 | 9.94 | 9.65 | -0.15 | -1.51 | (1) | 原料藥/學名藥/新藥 | 0.591 | 98.7 | +144.6 | - | 1.89 | 98.9 | - | | (2) | 體溫量測產品 | 0.0075 | 1.25 | - | -91.5 | - | - | - | | 減 | 銷貨退回及折讓 | 0 | 0 | - | - | 0 | 0 | - | | 合計 | 業務營收淨額 | 0.598 | 100 | +147.7 | +21.6 | 1.91 | 100 | +8.7 | | 月別 | 當月股價 | 項目 | 產品/業務 | 單月營收 | 累計營收 | | 開盤 | 收盤 | 最高 | 最低 | 漲跌
(元) | 漲跌
(%) | 營收
(億) | 佔比
(%) | 月增
(%) | 年增
(%) | 營收
(億) | 佔比
(%) | 年增
(%) | | 2019/05 | 11.75 | 9.95 | 11.8 | 9.7 | -1.8 | -15.32 | (1) | 原料藥/學名藥/新藥 | 0.241 | 100 | +2.46 | - | 1.3 | 99 | - | | 減 | 銷貨退回及折讓 | 0 | 0 | - | - | 0 | 0 | - | | 合計 | 業務營收淨額 | 0.241 | 100 | +2.46 | +54.5 | 1.31 | 100 | +3.7 |
|
